2-氯-5-氟苯并噻唑 | 154327-27-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 2-氯-5-氟苯并噻唑
• 英文名称: 2-chloro-5-fluorobenzo[d]thiazole
• 英文别名: 2-chloro-5-fluorobenzothiazole；2-chloro-5-fluoro-1,3-benzothiazole
• CAS: 154327-27-2
• 化学式: C₇H₃ClFNS
• mdl: MFCD09749234
• 分子量: 187.625
• InChiKey: IHMBREJYLPBYSM-UHFFFAOYSA-N

物化性质

• 沸点：
  253.0±13.0 °C(Predicted)
• 密度：
  1.532±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  2-氯-5-氟苯并噻唑 在 potassium carbonate 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 N1-(5-fluorobenzo[d]thiazol-2-yl)propane-1,3-diamine
  参考文献：
  名称：

  Preparation, antibacterial evaluation and preliminary structure–activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives

  摘要：

  In this study, a novel benzothiazol- and benzooxazol-2-amine scaffold with antibacterial activity was designed and synthesized. Preliminary structure-activity relationship analysis displayed that compound 8t with a 5,6-difluorosubstituted benzothiazole was found to be a potent inhibitor of Gram-positive pathogens, and exhibited some potential against drug-resistant bacteria and without cytotoxicity in therapeutic concentrations. In addition, molecular docking studies indicated that Staphylococcus aureus methionyl-tRNA synthetase might be the possible target of these compounds. Taken together, the present study provides an effective entry to the synthesis of a good lead for subsequent optimization and a new small molecule candidate drug for antibacterial therapeutics. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.03.079
• 作为产物：
  描述：

  2,5-二氟苯胺 在 磺酰氯 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 100.25h， 生成 2-氯-5-氟苯并噻唑
  参考文献：
  名称：

  [EN] HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS
  [FR] COMPOSÉS D'HÉTÉROARYLOXYCARBOCYCLYLE CONVENANT COMME INHIBITEURS DE LA PDE10

  摘要：

  式(I)的杂芳基氧基环底碳基化合物，以及含有它们的组合物，以及制备这类化合物的方法。本文还提供了通过抑制PDE10治疗可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、亨廷顿病、躁郁症、强迫症等。公式(I)

  公开号：

  WO2011143366A1

文献信息

• HETEROBICYCLIC COMPOUNDS
  申请人：Amgen Inc.

  公开号：US20130225552A1

  公开（公告）日：2013-08-29

  Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.

  Formula (I)的杂环化合物： 或其药用可接受的盐、互变异构体或立体异构体，如规范中所定义，并含有它们的组合物，以及制备这种化合物的方法。本文还提供了通过抑制PDE10来治疗由此可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、躁郁症、强迫症、亨廷顿病等。
• Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
  作者：Marco Migliore、Silvia Pontis、Angel Luis Fuentes de Arriba、Natalia Realini、Esther Torrente、Andrea Armirotti、Elisa Romeo、Simona Di Martino、Debora Russo、Daniela Pizzirani、Maria Summa、Massimiliano Lanfranco、Giuliana Ottonello、Perrine Busquet、Kwang-Mook Jung、Miguel Garcia-Guzman、Roger Heim、Rita Scarpelli、Daniele Piomelli

  DOI：10.1002/anie.201603746

  日期：2016.9.5

  intracellular cysteine amidase, N‐acylethanolamine acid amidase (NAAA). Even though NAAA may offer a new target for anti‐inflammatory therapy, the lipid‐like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs. A series of novel benzothiazole–piperazine derivatives that inhibit NAAA in a potent and selective manner by a non‐covalent mechanism are

  棕榈酰乙醇酰胺（PEA）和油酰乙醇酰胺（OEA）是抑制炎症的内源性脂质介体。它们的作用被细胞内半胱氨酸酰胺酶，N-酰基乙醇胺酸酰胺酶（NAAA）终止。尽管NAAA可能为抗炎治疗提供新的靶标，但目前NAAA抑制剂的类脂质结构和反应弹头限制了将这些试剂用作口服药物。描述了一系列通过非共价机制有效和选择性抑制NAAA的新型苯并噻唑-哌嗪衍生物。此类的原型成员（8）在多发性硬化症（MS）的小鼠模型中显示出较高的口服生物利用度，可进入中枢神经系统（CNS）的功能以及强大的活动。该化合物是第二代非共价NAAA抑制剂的例证，可用于治疗MS和其他慢性CNS疾病。
• [EN] BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS<br/>[FR] COMPOSÉS BICYCLIQUES SUBSTITUÉS PAR HÉTÉROARYLE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018013774A1

  公开（公告）日：2018-01-18

  Disclosed are compounds of Formula (I) to (VIII): (I) (II) (III) (IV) (V) (VI) (VII) (VIII); or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a bicyclic heteroaryl group substituted with zero to 3 R3a; and R1, R2, R3a, R4, and n are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors, and pharmaceutical compositions comprising such compounds. These compounds are useful in inhibiting or preventing platelet aggregation, and are useful for the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder.

  公开了公式(I)至(VIII)的化合物：(I) (II) (III) (IV) (V) (VI) (VII) (VIII)；或其立体异构体、互变异构体、药物可接受的盐、溶剂化物或前药，其中R3是与0至3个R3a取代的双环杂芳基团；且R1、R2、R3a、R4和n在此定义。还公开了使用这些化合物作为PAR4抑制剂的方法，以及包含这些化合物的药物组合物。这些化合物用于抑制或预防血小板聚集，用于治疗血栓栓塞障碍或作为血栓栓塞障碍的初级预防。
• Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
  申请人：Bayer Pharmaceuticals Corporation

  公开号：US20040224997A1

  公开（公告）日：2004-11-11

  This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

  这项发明涉及某些芳基烷基酸化合物、组合物以及治疗或预防肥胖和相关疾病的方法。
• Divergent S- and C-Difluoromethylation of 2-Substituted Benzothiazoles
  作者：Xiu Wang、Wenchao Ye、Taige Kong、Chenlu Wang、Chuanfa Ni、Jinbo Hu

  DOI：10.1021/acs.orglett.1c03267

  日期：2021.11.5

  Two unprecedented and complementary synthetic strategies for S- and C-difluoromethylation of 2-substituted benzothiazoles have been developed by taking advantage of the remarkably different reactivity of CF2H– and 2-PySO2CF2– nucleophiles. A variety of structurally diverse difluoromethyl 2-isocyanophenyl sulfides and 2-difluoromethylated benzothiazoles were synthesized with these two new synthetic

  利用 CF 2 H和 2 - PySO 2 CF 2亲核试剂的显着不同反应性，开发了两种前所未有的互补合成策略，用于 2-取代的苯并噻唑的 S-和 C-二氟甲基化。用这两种新的合成方案合成了多种结构多样的二氟甲基 2-异氰基苯硫醚和 2-二氟甲基苯并噻唑。